Company Filing History:
Years Active: 1998-2000
Title: Innovations by Xiaoying Qiao
Introduction
Xiaoying Qiao is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of hematology through his innovative patents. With a total of 3 patents, Qiao's work focuses on serum-free suspensions of human hematopoietic cells and methods for treating neutropenia.
Latest Patents
Qiao's latest patents include the preparation of serum-free, animal protein-free media formulations designed for the in vitro growth of human neutrophil and megakaryocyte precursors. These formulations contain a base medium along with corticosteroid, transferrin, insulin, cholesterol, ethanolamine, and human albumin. His inventions provide methods for preparing these suspensions, ensuring that the cellular component contains a significant percentage of neutrophil and megakaryocyte precursors. Additionally, he has developed a method for treating patients with reduced neutrophil populations following myeloablative cancer treatments, which involves administering a cell composition rich in neutrophil precursors.
Career Highlights
Xiaoying Qiao is currently associated with Nexell Therapeutics Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of patients undergoing chemotherapy and those with hematological disorders.
Collaborations
Qiao collaborates with esteemed colleagues, including Stephen L. Smith and Susan M. Maciukas, who contribute to his research endeavors and innovations in the field.
Conclusion
Xiaoying Qiao's contributions to the field of hematology through his innovative patents demonstrate his commitment to improving patient care and treatment options. His work continues to pave the way for advancements in medical science.